John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$106M |
| 2 |
Newmark Group
NMRK
|
+$13M |
| 3 |
NovaGold Resources
NG
|
+$4.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.23% |
| 2 | Materials | 34.94% |
| 3 | Financials | 15.48% |
| 4 | Technology | 3.67% |
| 5 | Real Estate | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Madrigal Pharmaceuticals
MDGL
$11.9B
| $256M | 23.09% |
1,105,741
+605,741
| +121% | +$106M |
|
2
Bausch Health
BHC
$2.41B
| $212M | 19.14% |
26,439,035
| – | – |
|
|
AAMI
3
Acadian Asset Management
AAMI
$3.28B
| $171M | 15.48% |
8,950,121
| – | – |
|
|
4
NovaGold Resources
NG
$3.83B
| $88M | 7.95% |
23,541,483
+1,315,183
| +6% | +$4.94M |
|
|
PPTA
5
Perpetua Resources
PPTA
$3.21B
| $78.5M | 7.09% |
24,771,542
| – | – |
|
6
AngloGold Ashanti
AU
$61.3B
| $71.6M | 6.47% |
3,833,492
| – | – |
|
7
Agnico Eagle Mines
AEM
$109B
| $43M | 3.88% |
783,561
| – | – |
|
8
Thryv Holdings
THRY
$92.4M
| $40.7M | 3.67% |
2,000,000
| – | – |
|
|
THM
9
International Tower Hill Mines
THM
$735M
| $36.2M | 3.27% |
61,930,724
| – | – |
|
|
10
Newmark Group
NMRK
$2.94B
| $32.9M | 2.97% |
3,000,000
+1,715,375
| +134% | +$13M |
|
|
SA
11
Seabridge Gold
SA
$3.25B
| $25.1M | 2.27% |
2,070,000
| – | – |
|
12
SSR Mining
SSRM
$7.7B
| $21.5M | 1.94% |
2,000,000
| – | – |
|
13
Equinox Gold
EQX
$15.8B
| $12.2M | 1.1% |
2,500,000
| – | – |
|
|
TMQ
14
Trilogy Metals
TMQ
$684M
| $6.16M | 0.56% |
14,326,996
| – | – |
|
15
IAMGOLD
IAG
$12.1B
| $4.68M | 0.42% |
1,850,000
| – | – |
|
|
TELL
16
DELISTED
Tellurian Inc.
TELL
| $4.04M | 0.36% |
5,340,663
| – | – |
|
17
Alibaba
BABA
$286B
| $3.88M | 0.35% |
50,000
| – | – |
|
|
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-2,103,046
| Closed | -$243M |
|
Similar funds
John Paulson's Q4 2023 Portfolio in Review
As of Q4 2023, John Paulson held 18 positions worth $1.11B, down 0.86% from $1.12B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
John Paulson withdrew a net $119M in Q4 2023, closing 1 position. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $243M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Materials and Financials.
Against the trend, John Paulson added an estimated $106M to Madrigal Pharmaceuticals.
- John Paulson added most to Madrigal Pharmaceuticals in Q4 2023, an estimated $106M increase.
- John Paulson fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $243M.
- John Paulson's ten largest holdings make up 93% of its $1.11B portfolio in Q4 2023.
- John Paulson opened 0 new positions and closed 1 in Q4 2023.
- John Paulson's portfolio value fell 0.86% quarter-over-quarter to $1.11B.
Based on Paulson & Co's 13F filing for Q4 2023, filed 14 Feb 2024.